247 related articles for article (PubMed ID: 27524613)
1. Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.
Kandaswamy R; Sava GP; Speedy HE; Beà S; Martín-Subero JI; Studd JB; Migliorini G; Law PJ; Puente XS; Martín-García D; Salaverria I; Gutiérrez-Abril J; López-Otín C; Catovsky D; Allan JM; Campo E; Houlston RS
Cell Rep; 2016 Aug; 16(8):2061-2067. PubMed ID: 27524613
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia (CLL) risk is mediated by multiple enhancer variants within CLL risk loci.
Yan H; Tian S; Kleinstern G; Wang Z; Lee JH; Boddicker NJ; Cerhan JR; Kay NE; Braggio E; Slager SL
Hum Mol Genet; 2020 Sep; 29(16):2761-2774. PubMed ID: 32744316
[TBL] [Abstract][Full Text] [Related]
4. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
[TBL] [Abstract][Full Text] [Related]
5. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
Berndt SI; Skibola CF; Joseph V; Camp NJ; Nieters A; Wang Z; Cozen W; Monnereau A; Wang SS; Kelly RS; Lan Q; Teras LR; Chatterjee N; Chung CC; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Armstrong BK; Cocco P; Zhang Y; Severi G; Zeleniuch-Jacquotte A; Lawrence C; Burdette L; Yuenger J; Hutchinson A; Jacobs KB; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Wang AH; Smedby KE; Adami HO; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Jones B; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Holly EA; Smith MT; Jackson RD; Tinker LF; Benavente Y; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Leis JF; Cunningham JM; Weinberg JB; Morrison VA; Caporaso NE; Norman AD; Linet MS; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Masala G; Weiderpass E; Chirlaque MD; Vermeulen RC; Travis RC; Giles GG; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Offit K; Zelenetz A; Klein RJ; Spinelli JJ; Bertrand KA; Laden F; Giovannucci E; Kraft P; Kricker A; Turner J; Vajdic CM; Ennas MG; Ferri GM; Miligi L; Liang L; Sampson J; Crouch S; Park JH; North KE; Cox A; Snowden JA; Wright J; Carracedo A; Lopez-Otin C; Bea S; Salaverria I; Martin-Garcia D; Campo E; Fraumeni JF; de Sanjose S; Hjalgrim H; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Nat Genet; 2013 Aug; 45(8):868-76. PubMed ID: 23770605
[TBL] [Abstract][Full Text] [Related]
7. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia.
Ott CJ; Federation AJ; Schwartz LS; Kasar S; Klitgaard JL; Lenci R; Li Q; Lawlor M; Fernandes SM; Souza A; Polaski D; Gadi D; Freedman ML; Brown JR; Bradner JE
Cancer Cell; 2018 Dec; 34(6):982-995.e7. PubMed ID: 30503705
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Law PJ; Sud A; Mitchell JS; Henrion M; Orlando G; Lenive O; Broderick P; Speedy HE; Johnson DC; Kaiser M; Weinhold N; Cooke R; Sunter NJ; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Carmichael J; Bailey JR; Pratt G; Rahman T; Pepper C; Fegan C; von Strandmann EP; Engert A; Försti A; Chen B; Filho MI; Thomsen H; Hoffmann P; Noethen MM; Eisele L; Jöckel KH; Allan JM; Swerdlow AJ; Goldschmidt H; Catovsky D; Morgan GJ; Hemminki K; Houlston RS
Sci Rep; 2017 Jan; 7():41071. PubMed ID: 28112199
[TBL] [Abstract][Full Text] [Related]
9. Distribution of rs2124594 genotypes in chronic lymphocytic leukemia patients depending on radiation anamnesis.
Bilous NI; Abramenko IV; Chumak AA; Diagil IS; Martina ZV
Probl Radiac Med Radiobiol; 2017 Dec; 22():323-331. PubMed ID: 29286517
[TBL] [Abstract][Full Text] [Related]
10. Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.
Sava GP; Speedy HE; Di Bernardo MC; Dyer MJ; Holroyd A; Sunter NJ; Marr H; Mansouri L; Deaglio S; Karabon L; Frydecka I; Jamroziak K; Woszczyk D; Juliusson G; Smedby KE; Jayne S; Majid A; Wang Y; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Leukemia; 2015 Mar; 29(3):748-51. PubMed ID: 25363670
[No Abstract] [Full Text] [Related]
11. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.
Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM
Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
Berndt SI; Camp NJ; Skibola CF; Vijai J; Wang Z; Gu J; Nieters A; Kelly RS; Smedby KE; Monnereau A; Cozen W; Cox A; Wang SS; Lan Q; Teras LR; Machado M; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Vajdic CM; Cocco P; Zhang Y; Giles GG; Zeleniuch-Jacquotte A; Lawrence C; Montalvan R; Burdett L; Hutchinson A; Ye Y; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Cunningham JM; Allmer C; Hjalgrim H; Adami HO; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Arnett DK; Zhi D; Leach JM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Sala N; Casabonne D; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Chaffee KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Leis JF; Weinberg JB; Caporaso NE; Norman AD; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Masala G; Weiderpass E; Chirlaque MD; Vermeulen RCH; Travis RC; Southey MC; Milne RL; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Villano DJ; Maria A; Spinelli JJ; Gascoyne RD; Connors JM; Bertrand KA; Giovannucci E; Kraft P; Kricker A; Turner J; Ennas MG; Ferri GM; Miligi L; Liang L; Ma B; Huang J; Crouch S; Park JH; Chatterjee N; North KE; Snowden JA; Wright J; Fraumeni JF; Offit K; Wu X; de Sanjose S; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Nat Commun; 2016 Mar; 7():10933. PubMed ID: 26956414
[TBL] [Abstract][Full Text] [Related]
14. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
15. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
Mallm JP; Iskar M; Ishaque N; Klett LC; Kugler SJ; Muino JM; Teif VB; Poos AM; Großmann S; Erdel F; Tavernari D; Koser SD; Schumacher S; Brors B; König R; Remondini D; Vingron M; Stilgenbauer S; Lichter P; Zapatka M; Mertens D; Rippe K
Mol Syst Biol; 2019 May; 15(5):e8339. PubMed ID: 31118277
[TBL] [Abstract][Full Text] [Related]
16. Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells.
Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
Leukemia; 2004 Jan; 18(1):41-7. PubMed ID: 14574334
[TBL] [Abstract][Full Text] [Related]
17. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
18. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
19. BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.
Majid A; Tsoulakis O; Walewska R; Gesk S; Siebert R; Kennedy DB; Dyer MJ
Blood; 2008 Jan; 111(2):874-7. PubMed ID: 17959858
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
